Voltaren Arthritis Pain Gel for everyday joint relief

Voltaren Arthritis Pain Gel offers prescription-strength diclofenac in an over-the-counter gel that targets joint pain directly at the source for many US adults with osteoarthritis.

Voltaren Arthritis Pain Gel is a nonprescription diclofenac gel for joint pain that became available over the counter in the United States in 2020 after FDA approval in February 2020 FDA, 02/14/2020.

As of: 05/21/2026 | Reading time: approx. 8 minutes

By the AD HOC NEWS editorial team - specialized in product-focused market coverage.

At a Glance

• Product: Voltaren Arthritis Pain Gel
• Category: Topical nonsteroidal anti-inflammatory gel
• Brand/Manufacturer: Voltaren - Haleon
• Primary Use Cases: Temporary relief of arthritis pain in joints such as hands, wrists, elbows, knees, ankles, and feet
• Availability: Over the counter at pharmacies, grocery stores, mass retailers, and online across the United States
• Core Markets: United States, Europe, and other regions where Voltaren topical diclofenac is approved

What Voltaren Arthritis Pain Gel Is and How It Works

Voltaren Arthritis Pain Gel is a topical nonsteroidal anti-inflammatory drug based on diclofenac sodium 1% in the US version (equivalent to 1% diclofenac diethylamine in many other markets) Voltaren US, 2024.

Instead of being swallowed like an oral tablet, the gel is applied directly to the skin over the painful joint. The active ingredient is designed to penetrate the skin and act locally in the tissues around the joint, where it inhibits cyclooxygenase enzymes involved in prostaglandin production FDA prescribing information, 03/2020.

Because Voltaren Arthritis Pain Gel is used on the skin, systemic exposure to diclofenac is lower compared with many oral NSAIDs at labeled doses, which can be relevant for patients who need targeted pain relief and want to limit systemic NSAID use FDA prescribing information, 03/2020.

The gel is usually supplied in tubes that include a dosing card in US packs, helping users measure the correct ribbon length for small or large joints. Typical directions are to apply the product four times daily to affected joints as needed, up to the labeled maximum per joint and per day Voltaren US, 2024.

Voltaren Arthritis Pain Gel is indicated in the United States for the temporary relief of arthritis pain in joints that are amenable to topical therapy, such as hands, wrists, elbows, knees, ankles, and feet. It is not intended for use on the spine, hip, or shoulder joints in the US OTC label FDA prescribing information, 03/2020.

Why Voltaren Arthritis Pain Gel Matters for US Consumers and Industry

Many adults in the United States live with osteoarthritis and joint pain. The Centers for Disease Control and Prevention has described osteoarthritis as the most common form of arthritis among US adults, affecting joints such as knees and hands in daily activities CDC, 03/11/2024.

For US consumers, having diclofenac available in a topical nonprescription option such as Voltaren Arthritis Pain Gel can be useful when managing localized joint pain as part of a broader arthritis plan that may include physical therapy, weight management, and other medications directed by health care professionals Arthritis Foundation, 2024.

Topical NSAID options like Voltaren Arthritis Pain Gel are also part of clinical guidance for certain patients with osteoarthritis. In 2020, the American College of Rheumatology and Arthritis Foundation guideline on osteoarthritis management described topical NSAIDs as a recommended option for knee osteoarthritis in many adults, particularly when systemic exposure is a concern American College of Rheumatology/Arthritis Foundation, 01/2020.

For the consumer health industry, Voltaren Arthritis Pain Gel represents a category where prescription molecules have moved into over-the-counter formats, allowing pharmacy shelves and online retailers to offer options that were previously prescription-only, within the dosing and indication limits defined by regulators FDA, 02/14/2020.

Voltaren Arthritis Pain Gel in the US and Global Market

Voltaren as a brand has been marketed internationally for decades in oral and topical diclofenac forms, and Voltaren Arthritis Pain Gel is the specific US over-the-counter topical gel formulation available for arthritis pain relief in joints suitable for topical treatment Novartis, 03/28/2018.

In the United States, the gel is typically found in major pharmacy chains, mass retailers, grocery stores with pharmacy sections, and online marketplaces. Consumer healthcare company Haleon highlights Voltaren Arthritis Pain Gel as one of its key pain relief brands in its self-care portfolio Haleon, 2024.

Outside the US, related Voltaren topical formulations are available as diclofenac diethylamine gels or emulsions for musculoskeletal pain and osteoarthritis, subject to country-specific indications and prescription status. Labeling and strength can differ, so consumers in each country need to follow local packaging and talk with health professionals Medsafe New Zealand, 03/2021.

• Topical diclofenac gel targeting joint pain where applied
• Over-the-counter availability across the United States
• Used up to four times daily on labeled joints
• Intended for osteoarthritis symptom relief in adults
• Pack includes a dosing card for measuring gel amounts

Voltaren is a consumer healthcare pain relief brand now managed globally by Haleon, which focuses on nonprescription medicines and wellness products sold through pharmacies, retailers, and online channels.

Haleon shares are listed on the London Stock Exchange, and the companys equity has been associated with ISIN GB0009252882 in capital markets data, reflecting its role as the issuer behind the Voltaren consumer health brand.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.